DIFLUOROMETHYLORNITHINE FOR ARSENO-RESISTANT TRYPANOSOMA BRUCEI GAMBIENSE SLEEPING SICKNESS

26 patients with arseno-resistant Trypanosoma brucei gambiense trypanosomiasis were treated with difluoromethylornithine (eflornithine), an inhibitor of ornithine decarboxylase, given intravenously, then orally. There was rapid disappearance of trypanosomes in the cerebrospinal fluid (CSF), gradual decrease of CSF lymphocytosis, and parallel improvement in central nervous system status. Side-effects, including diarrhoea, anaemia, and hair loss, were common but tolerable and reversible. 5 patients died during or shortly after treatment. None of the 21 patients who completed therapy has had a relapse during the 6-30 month follow-up.

[1]  B. Greenwood,et al.  The pathogenesis of sleeping sickness. , 1980, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  L Haller,et al.  Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy. , 1986, The American journal of tropical medicine and hygiene.

[3]  P. Schechter,et al.  Kinetics of α‐difluoromethylornithine: An irreversible inhibitor of ornithine decarboxylase , 1981, Clinical pharmacology and therapeutics.

[4]  P. McCann,et al.  Polyamine metabolism: a potential therapeutic target in trypanosomes. , 1980, Science.

[5]  A. Sjoerdsma,et al.  Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. , 1987, The American journal of medicine.

[6]  A. Sjoerdsma,et al.  Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  P. McCann,et al.  New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin. , 1984, The American journal of tropical medicine and hygiene.

[8]  A. Sjoerdsma,et al.  Chemotherapeutic implications of polyamine biosynthesis inhibition , 1984, Clinical pharmacology and therapeutics.

[9]  D. Ray,et al.  Diagnosis of African and American trypanosomiases. , 1985 .